Strategic Initiatives Director - Enterprise Execution

Haemonetics Interventional Technologies; Boston (MA); Híbrido; USD 179 000 - 305 000; Tempo integral

Vantagens oferecidas por esta oferta de emprego

401(k) with up to 6% employer match

Employee stock purchase plan

Flexible time off

Resumo da oferta

Haemonetics Interventional Technologies in Boston, MA is seeking a Senior Director, Strategy & Corporate Initiatives to translate long-term plans into actionable priorities. You will lead cross-functional teams, govern strategic programs, and drive execution across the enterprise.

You will partner with the SVP and Executive Leadership to manage growth initiatives, M&A integrations, and portfolio transformations with rigorous analysis and measurable outcomes.

Qualificações

• 10+ years in corporate strategy or related fields.
• Experience with M&A integration, divestitures or significant partnerships in the healthcare industry.
• Successful direct or indirect people management experience; leading teams and projects.

Responsabilidades

• Translate strategy into clear priorities and initiatives across the organization.
• Lead or support high-priority enterprise initiatives that cut across functions.
• Navigate and align multiple senior stakeholders to move initiatives from open questions to results.
• Run or support Integration Management Office (IMO) for deals and partnerships.

Conhecimentos

Strategic leadership

Cross-functional leadership

Stakeholder management

Analytical thinking

Execution oriented

Formação académica

Bachelor's degree in business/finance

Master's degree preferred

Descrição da oferta de emprego

Haemonetics Interventional Technologies in Boston, MA is seeking a Senior Director, Strategy & Corporate Initiatives to translate long-term plans into actionable priorities. You will lead cross-functional teams, govern strategic programs, and drive execution across the enterprise.

You will partner with the SVP and Executive Leadership to manage growth initiatives, M&A integrations, and portfolio transformations with rigorous analysis and measurable outcomes.